

SUBSCRIBE TO OUR FREE NEWSLETTER
Daily news & progressive opinion—funded by the people, not the corporations—delivered straight to your inbox.
5
#000000
#FFFFFF
To donate by check, phone, or other method, see our More Ways to Give page.


Daily news & progressive opinion—funded by the people, not the corporations—delivered straight to your inbox.

Sumer Shaikh, Green New Deal Network, sshaikh@greennewdealnetwork.org
Former HI State Rep. Kaniela Ing Will Lead Network’s Push for a Green New Deal Agenda Beyond the Inflation Reduction Act (IRA)
Today, the Green New Deal Network (GNDN) unveiled its 2023 agenda to be spearheaded by former Hawaii State Representative Kaniela Ing as GNDN’s first-ever National Director. Ing will build on GNDN’s major 2022 wins, including helping secure major climate provisions in the Inflation Reduction Act (IRA); blocking Senator Manchin’s dirty side deal, and seeing 26 out of its 31 endorsed candidates win in the general elections. Over the next year, under Ing’s leadership, the GNDN will campaign with its 24 state coalitions for the equitable implementation of federal infrastructure and climate dollars, local Green New Deal policies that build off of the IRA, and greater public support for climate justice through public education.
Ing is a founding member of the Network — a multisectoral coalition of 14 national organizations and 24 state tables— and previously acted as the Climate Justice Director for People's Action, where he led campaigns to combat climate change. While at People’s Action, Ing co-created and led mass mobilizations around the People’s Bailout and THRIVE Agenda, which largely shaped the suite of federal legislation.
As a state representative in Hawaii, Ing helped pass the nation’s first statewide 100% renewable energy goal, drove hundreds of millions of public investments into green schools and transit, and expanded democracy by passing with the nation’s most expansive elections reform effort which included online registration, same-day registration, and all-mail elections.
“The fight for a Green New Deal is at a pivotal moment where we have a slim opportunity to win community investments that can halt the climate crisis, create dignified jobs, and reverse decades-old injustices. We need community leaders and activists to rally politicians to act boldly on all levels of government and fund a cleaner, fairer, and more reliable future for generations to come. Anything short of that will put millions of lives in danger and widen the inequities that permeate our economy,” said Kaniela Ing, National Director of the Green New Deal Network. “Our network and allies have already secured tremendous victories with the passage of the Inflation Reduction Act. But we always knew this bill would only mark the start, not the end, of our movement’s work toward climate justice. I’m thrilled and honored to lead the charge with our allies to help make the Green New Deal a reality.”
The Green New Deal Network is uniquely positioned to win local Green New Deal legislation, support progressive candidates, and ensure federal infrastructure and climate funding goes to community-led solutions. In 2023, the Network’s 14 national and 24 state members are moving as a united front to:
“Last year taught us a lot about climate advocacy and what effective campaigning and support for the communities most affected by climate change looks like,” said Bineshi Albert, Co-Executive Director of Climate Justice Alliance. “I’m confident that the Coalition’s new goals, alongside the leadership of Kaniela Ing will put climate wins on the board for the communities who most need them. Mother Earth deserves our honor and good stewardship. I trust in Kaniela’s leadership and in the vision he and the Green New Deal Network has to fight for our climate, jobs, and justice.”
“Climate change is an economic issue, but not for the reason folks most often think. By investing in a Green New Deal and creating good, clean jobs for working families, we not only address the climate change harms faced by working folks, we ensure everyone is able to financially thrive,” said Maurice Mitchell, National Director of the Working Families Party. “This year, the Green New Deal Network is hitting the ground running with new leadership and a realignment of our goals to mobilize and put pressure on lawmakers to make bold investments in clean energy and clean jobs for working families. I have faith in Kaniela and his vision for the future of our coalition and our planet.”
About Kaniela Ing
Kaniela Ing is a movement leader and community organizer with over 14 years of experience in legislative, electoral, and community-building campaigns. He comes from a working-class, environmental justice community and first started organizing through the movement for Native Hawaiian sovereignty.
Kaniela turned to electoral politics in response to Barack Obama's presidential win and the right-wing backlash that followed. He was elected to the Hawaii State Legislature at age 23 —as a bold progressive in a "red-leaning" district—where he co-led fights to strengthen democracy, advance justice, and pass the nation's first statewide 100% renewable energy goal. He later led the national climate work at Peoples' Action, where he helped to shape the THRIVE agenda, build up the Green New Deal Network, and pass the most consequential piece of federal climate legislation in United States history.
Kaniela is a proud Kānaka Maoli (Native Hawaiian), feminist, spouse, and parent of two young children. Kaniela serves on the advisory teams of Climate Power, Our Hawaii Action, the Hawaii Community Bail Fund, and the Indigenous Circle of Giving. In his free time, Kaniela likes to write and record music and explore the wonders of the natural world.
The Green New Deal Network is a 50-state campaign with a national table of 15 organizations: Center for Popular Democracy, Climate Justice Alliance, Grassroots Global Justice Alliance, Greenpeace, Indigenous Environmental Network, Indivisible, Movement for Black Lives, MoveOn, People's Action, Right To The City Alliance, Service Employees International Union, Sierra Club, Sunrise Movement, US Climate Action Network, and the Working Families Party.
"Trump has dressed up yet another corporate giveaway as a boon to patients," said one watchdog. "Real drug price reform doesn’t look like a website."
US President Donald Trump on Thursday launched a website, branded with his name, in a purported effort to help patients buy prescription drugs at lower prices.
But experts, watchdog groups, and Democratic lawmakers said TrumpRx will likely do little for consumers—or for the broader goal of bringing down exorbitant medicine costs—while further enriching Big Pharma and potentially lining the pockets of his eldest son, Donald Trump Jr.
TrumpRx.gov, launched in partnership with pharmaceutical giants, points users to direct-to-patient sales platforms hosted by drug companies to facilitate the purchase of an extremely limited selection of medications. For example, TrumpRx's listing for Farxiga links users to AstraZeneca Direct, where patients can pay out of pocket for the type 2 diabetes medication.
Donald Trump Jr. is on the board of BlinkRx, a prescription drug platform that stands to benefit from the Trump administration's promotion of direct-to-patient medicine sales. In December, the president's son reportedly met with top drug company executives and administration officials responsible for regulating the pharmaceutical industry—a gathering hosted by BlinkRx.
Frank Pallone Jr. (D-NJ), the top Democrat on the House Energy and Commerce Committee, said in a statement Thursday that TrumpRx "not only threatens patients’ health, safety, and privacy, but also likely includes kickback schemes designed to enrich President Trump, his family, and their friends."
"TrumpRx has been shrouded in secrecy from the beginning because the administration clearly does not want anyone to know it likely won’t save patients money," said Pallone. "However, we do know Trump only slaps his name on things when there’s something in it for him."
Last week, a group of Democratic senators sent a letter to the inspector general of the US Department of Health and Human Services warning that "without stricter safeguards before its official launch, TrumpRx could be used as a potential vehicle for unlawful kickback schemes that result in excessive costs for the federal government."
In addition to sending users to direct-to-patient sales sites, TrumpRx offers Trump-branded coupons for some medications. To obtain a coupon, site users must accept terms that state: "You agree that by redeeming this coupon, you (and anyone else acting on your behalf) agree not to seek reimbursement from any insurance plan for out-of-pocket costs for prescriptions purchased with this coupon. You also agree not to count the cost of prescriptions toward your deductible or true out-of-pocket costs."
The Washington Post reported that pharmaceutical companies "have agreed to list their drugs on TrumpRx.gov."
"TrumpRx is designed to help Big Pharma keep its prices high by diluting the bargaining power of insurance companies, weakening an important check on pharma."
Experts warned that patients who use TrumpRx could end up paying more for their medications than if they pursued other available options.
"TrumpRx’s offerings are very limited, fewer than 50 drugs listed, and most are niche products used by few patients," Rena Conti, an associate professor at Boston University, told ABC News. "Many are available in generic form at even lower prices or already available to consumers at low or even very low prices elsewhere. This suggests it pays for consumers to check their insurance coverage and ask their regular doctor or pharmacist before they use this service."
Peter Maybarduk, access to medicines director at Public Citizen, offered a more scathing assessment of TrumpRx, saying the president has "dressed up yet another corporate giveaway as a boon to patients."
"Most patients will do better through their insurance than through TrumpRx. Many patients without insurance will not be able to afford drugmakers’ still-high prices funneled through TrumpRx," said Maybarduk. "But drugmakers certainly will appreciate TrumpRx’s free promotion of their products, delivered with a false veneer of price accountability. TrumpRx is designed to help Big Pharma keep its prices high by diluting the bargaining power of insurance companies, weakening an important check on pharma."
“TrumpRx also appears to be another example of this president’s repeated corruption," he continued. "Trump’s son, Donald Trump Jr., sits on the board of BlinkRx, a key business that may benefit financially from TrumpRx. Getting serious about medicine affordability means getting serious about challenging Big Pharma. For all Trump’s talk, Big Pharma is getting a lot of special favors from this White House, while patients still are waiting. Real drug price reform doesn’t look like a website."
Throughout his second White House term, Trump has made outlandish promises to cut drug costs and hosted top executives at the White House to tout splashy deals—only for pharmaceutical giants to continue jacking up prices. Reuters reported last month that drugmakers planned to "raise US prices on at least 350 branded medications, including vaccines against Covid, RSV, and shingles and blockbuster cancer treatment Ibrance" in 2026.
Merith Basey, CEO of Patients for Affordable Drugs Now, said in a statement that the Trump administration's "voluntary agreements" with drug companies "lack clear enforcement mechanisms and still put the power to set and increase prices firmly in the hands of pharmaceutical corporations."
"Patients in our community will soon learn if they can reliably access these discounts at the pharmacy counter, where the program will ultimately be tested and where affordability matters most," Basey said of TrumpRx.
"The most foundational racist idea is likening Black people to apes," said Howard University historian Ibram X. Kendi.
President Donald Trump, a documented racist, drew swift condemnation on Friday night after he posted a video on his Truth Social account depicting former President Barack Obama and first lady Michelle Obama as monkeys.
As reported by The Guardian, the racist depiction of the Obamas was part of a longer video that featured "false and disproven claims that ballot-counting company Dominion Voting Systems helped steal the 2020 presidential election" from Trump.
The outrage over the post was immediate, even as Trump's racism is well known and documented over many years.
"The most foundational racist idea is likening Black people to apes," said Howard University historian Ibram X. Kendi in a social media post. "Since humans evolved from an ape-like ancestor, racist ideas cast white people as the most evolved people and the furthest away on the evolutionary scale from apes. Racist ideas cast Black people as the least evolved people and the closest on the evolutionary scale to apes. Almost all racist ideas build on this foundational one expressed by Trump."
A screenshot of the video Trump shared:

Tom Jocelyn, senior fellow at the Reiss Center on Law and Security, predicted how Trump and his allies would defend his promotion of obvious racism.
"Let’s call out a game Trump and MAGA play," he wrote. "1. Trump posts, says or does something racist. 2. Some point out it’s racist. 3. Trump (with MAGA’s help) pretends to be the victim for being called a racist. MAGA stews in its imaginary grievances. 4. Rinse and repeat."
Mark Jacob, former metro editor at the Chicago Tribune, called out the New York Times for writing that it was "unclear if Mr. Trump was aware" that the racist depiction of the Obamas "had been included in the video before he shared it."
"What the hell is the New York Times doing?" he asked. "In its article on Trump posting a video that included a clip of the Obamas as apes, NYT tries to help him come up with an excuse."
Ben Rhodes, former deputy national security adviser under Obama, argued that Trump's post was yet another sign that he will be remembered as a deeply loathsome historical figure.
"Let it haunt Trump and his racist followers that future Americans will embrace the Obamas as beloved figures," he wrote, "while studying him as a stain on our history."
"It is time for us to focus on what really matters: unrigging this economy, making sure we reclaim our democracy—and it starts right now," Mejia said as the race officially remained too close to call.
This is a developing story... Please check back for updates...
Progressive organizer Analilia Mejia emerged late Thursday as the leader of a crowded Democratic primary race for a vacant US House seat representing New Jersey's 11th Congressional District, potentially notching a stunning upset in a contest that saw outside groups—including one linked to AIPAC—spend millions.
The bulk of that money came from the United Democracy Project (UDP), a billionaire-funded pro-Israel group that spent big to defeat former Rep. Tom Malinowski (D-NJ) in favor of its preferred candidate, Tahesha Way. The investment appears to have backfired in embarrassing fashion: Way is currently sitting in a distant third place, while UDP's attacks on Malinowski—regarded as a pro-Israel Democrat during his time in Congress—appear to have harmed him enough to propel Mejia, who has called Israel's assault on Gaza a genocide.
While the primary race is officially too close to call, some analysts said they expect Mejia to win after the remaining ballots are counted. As of this writing, Mejia—whose campaign was backed by Sen. Bernie Sanders (I-Vt.), Rep. Alexandria Ocasio-Cortez (D-NY), and other prominent progressives—is holding to a 486-vote lead.
"New Jersey, I am so excited to say that we have delivered people-powered victory," Mejia, a supporter of Medicare for All and other progressive policy ambitions, said in a video posted to social media shortly after midnight. "It is time for us to focus on what really matters: unrigging this economy, making sure we reclaim our democracy—and it starts right now."
My message to New Jersey voters. pic.twitter.com/8u8EBy02f7
— Analilia Mejia for NJ (@AnaliliaForNJ) February 6, 2026
The New Jersey Working Families Party, which endorsed and supported Mejia, said in a statement that "while every vote must still be counted, Analilia Mejia’s performance is historic."
"Analilia shocked the New Jersey political establishment and did what so many people said she couldn’t,” said Antoinette Miles, the organization's state director. “Voters are hungry for working-class leaders, and tonight they showed it.”
Prominent outlets, including Decision Desk HQ, were forced to retract their earlier projections of a Malinowski win after the progressive candidate took the lead. Mejia rubbed it in by posting to X the famous photo of Harry Truman holding up a copy of the Chicago Daily Tribune that featured the erroneous banner headline, "Dewey Defeats Truman."
The winner of the 11th Congressional District primary and April 16 general election will fill the remainder of New Jersey Gov. Mikie Sherrill's congressional term, which expires in January 2027.
Progressives who backed Mejia's campaign attributed her late surge to persistent organizing and a last-ditch advertising push. Rep. Pramila Jayapal (D-Wash.) noted that while Mejia "was outspent by millions," strategic spending by progressive PACs helped boost her campaign in the final days of the primary.
"When there’s a real organizer running, we don’t need to match $ for $—we just need to be in the ring," Jayapal wrote on social media late Thursday.
Observers also marveled at AIPAC's blundering intervention in the race. UDP's ads against Malinowski did not mention Israel; rather, one of the spots condemned the former congressman for voting in 2019 to fund President Donald Trump's "deportation force," possibly pushing voters toward the candidate who has called for the abolition of Immigration and Customs Enforcement (ICE).
"ICE is not reformable nor fixable, and New Jerseyans know this," Mejia said last month. "We need members of Congress who are willing to stand up to authoritarianism and terror. The same old blue just won’t cut it."